why choose us

First received: December 11, 2023

Clinical Trial: A Clinical Study of the V116 Vaccine for Children and Teenagers (V116-013)

Study Status: COMPLETED

Recruit Status: COMPLETED

Condition: Pneumococcal Infection

Study Type: INTERVENTIONAL


Official Title: A Phase 3, Randomized, Double-Blind Study to Evaluate the Safety, Tolerability, and Immunogenicity of V116 in Children and Adolescents With Increased Risk of Pneumococcal Disease

Brief Summary: The purpose of this study is to evaluate the safety, tolerability, and immunogenicity of V116 compared to PPSV23 in children 2 through 17 years of age.Researchers want to learn if V116 is as good as, or is better than the PPSV23 vaccine in terms of the antibody immune response.V116 and PPSV23 will be studied in children and teenagers who have a higher risk of getting invasive pneumococcal disease (IPD).

Read more